Improving Diabetes Outcomes With Activity, Nutrition and Medication

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Albert Einstein College of Medicine of Yeshiva University
ClinicalTrials.gov Identifier:
NCT00179374
First received: September 13, 2005
Last updated: April 27, 2009
Last verified: April 2009

September 13, 2005
April 27, 2009
July 2003
July 2008   (final data collection date for primary outcome measure)
  • Medication adherence [ Time Frame: 1 year ] [ Designated as safety issue: No ]
  • Metabolic control (measured by HbA1c) [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
  • Medication adherence
  • Metabolic control (measured by HbA1c)
Complete list of historical versions of study NCT00179374 on ClinicalTrials.gov Archive Site
  • Changes in self-care behaviors including diet and exercise [ Time Frame: 1 year ] [ Designated as safety issue: No ]
  • Cost evaluations [ Time Frame: 1 year ] [ Designated as safety issue: No ]
  • Changes in self-care behaviors including diet and exercise
  • Cost evaluations
 
 
 
Improving Diabetes Outcomes With Activity, Nutrition and Medication
Improving Diabetes Medication Adherence and Outcomes

This study has the following specific aims:

  1. A tailored telephone intervention will significantly improve medication adherence compared to a standard care intervention.
  2. A tailored telephone intervention will significantly improve metabolic control measured by HbA1c compared to a standard care intervention 2a) We will explore ways to link behavior change for medication adherence with lifestyle modification for diet and physical activity.
  3. To conduct cost evaluations for the telephone intervention vs. standard care.

Metabolic control of type 2 diabetes and prevention of its complications are related to management of blood glucose and other factors. Medication and lifestyle modifications are integral to most self-management plans; however, adherence remains a great challenge. Many patients have abnormal HbA1c, blood pressure and lipid values, and are at greater risk for complications. This study is to evaluate the effectiveness and costs of a tailored, telephone intervention to promote adherence in middle-aged and older adults with type-2 diabetes who are members of a union/employer-sponsored health benefit plan. The target population includes English- and Spanish-speaking individuals from the health plan database.

This study has the following specific aims:

  1. A tailored telephone intervention will significantly improve medication adherence compared to a standard care intervention.
  2. A tailored telephone intervention will significantly improve metabolic control measured by HbA1c compared to a standard care intervention 2a) We will explore ways to link behavior change for medication adherence with lifestyle modification for diet and physical activity.
  3. To conduct cost evaluations for the telephone intervention vs. standard care. The study design is a randomized, controlled intervention trial with masking; the individual is the unit of sampling, assignment and analysis. After eligibility is assessed and consent is obtained by telephone, patients will be randomized to either the telephone intervention or standard are. Study outcomes will be medication adherence as measured from pharmacy records and metabolic control (HbA1c). A total of 556 patients with type 2 diabetes wil be randomized, which will provide 80% power to detect a statistically significant difference in HbA1c of at least 0.3%, and over 95% power to detect a difference in filled prescriptions. Telephone surveys will provide data on self-care behaviors including diet and exercise, risk perceptions, and depressive symptoms. Cost data will be collected using standardized methods. Study results will inform implementation of practical, nurse-managed interventions to improve medication adherence and metabolic control in diverse, middle-aged and older, type 2 diabetes patients, while linking changes in medication adherence to lifestyle modification for diet and physical activity.
Interventional
 
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Diabetes Mellitus, Type 2
  • Behavioral: Tailored telephone intervention of education
    Tailored telephone intervention to promote metabolic control of diabetes
  • Behavioral: Print educational intervention
    diabetes educational materials by mail
  • Experimental: 1
    Tailored telephone intervention plus mailed print educational materials
    Intervention: Behavioral: Tailored telephone intervention of education
  • Active Comparator: 2
    print intervention with no telephone component
    Intervention: Behavioral: Print educational intervention
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
556
July 2008
July 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Type 2 diabetes
  • Taking oral diabetes medication
  • At least 40 years old
  • In a union-sponsored health plan with full medication coverage for at least a year
  • Able to understand English or Spanish
  • Informed consent

Exclusion Criteria:

  • Currently in a diabetes education program
  • Will lose health care eligibility within a year
  • Unable to receive phone calls or mail
Both
40 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00179374
#2003-068, 1 R18 DK062038-01A1
No
Elizabeth A. Walker, PhD, Principal Investigator, Albert Einstein College of Medicine
Albert Einstein College of Medicine of Yeshiva University
National Institutes of Health (NIH)
Principal Investigator: Elizabeth A Walker, DNSc, RN Albert Einstein College of Medicine of Yeshiva University
Principal Investigator: Hillel W Cohen, DrPH, MPH Albert Einstein College of Medicine of Yeshiva University
Albert Einstein College of Medicine of Yeshiva University
April 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP